1. Intrauterine and Lactational Exposure to Paracetamol: Cardiometabolic Evaluation in Adult Female and Male Offspring.
- Author
-
Novi DRBS, Vidigal CB, Moura KF, da Silva DG, Serafim AFL, Klein RM, Moreira EG, Gerardin DCC, and Ceravolo GS
- Subjects
- Adiposity drug effects, Animals, Aorta, Thoracic drug effects, Aorta, Thoracic physiopathology, Cardiovascular Diseases physiopathology, Female, Gestational Age, Hemodynamics drug effects, Insulin Resistance, Male, Metabolic Diseases blood, Metabolic Diseases physiopathology, Pregnancy, Rats, Wistar, Risk Assessment, Rats, Acetaminophen toxicity, Analgesics, Non-Narcotic toxicity, Cardiovascular Diseases chemically induced, Lactation, Metabolic Diseases chemically induced, Prenatal Exposure Delayed Effects
- Abstract
Abstract: Paracetamol (PAR) is the most common over-the-counter drug recommended by physicians for treatment of pain and fever during gestation. This drug is not teratogenic, being considered safe for fetus; however, PAR crosses the blood-placental barrier. Considering that, the present study aimed to evaluate the vascular and metabolic safety of PAR exposure during intrauterine and neonatal development in adult male and female-exposed offspring. Wistar female rats were gavaged, with PAR (350 mg/kg/d), from gestational day 6-21 or from gestational day 6 until postnatal day 21. Control dams received water by gavage at the same periods. The male and female offspring were evaluated at adulthood (80 days of life). The thoracic aorta reactivity to acetylcholine, sodium nitroprusside, and phenylephrine was evaluated in male and female adult offspring. It was observed that aortic relaxation was similar between the PAR and control offspring. In addition, the contraction to phenylephrine was similar between the groups. Further, the insulin sensitivity, adipose tissue deposition and blood pressure were not different between PAR and control adult offspring. These results suggest that the protocol of PAR exposure used in the present study did not program vascular and metabolic alterations that would contribute to the development of cardiometabolic diseases in adult life, being safe for the exposed offspring., Competing Interests: The authors report no conflicts of interest., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF